Systems biology approaches, leveraging multi-omics measurements, are needed to capture the 41 complexity of biological networks while identifying the key molecular drivers of disease 42 mechanisms. We present DIABLO, a novel integrative method to identify multi-omics 43 biomarker panels that can discriminate between multiple phenotypic groups. In the multi-omics 44 analyses of simulated and real-world datasets, DIABLO resulted in superior biological 45 enrichment compared to other integrative methods, and achieved comparable predictive 46 performance with existing multi-step classification schemes. DIABLO is a versatile approach 47 that will benefit a diverse range of research areas, where multiple high dimensional datasets are 48 available for the same set of specimens. DIABLO is implemented along with tools for model 49 selection, and validation, as well as graphical outputs to assist in the interpretation of these 50 integrative analyses (http://mixomics.org/). 51 52 55 56 57 3 Background 58
7 compartments, we hypothesized that they might provide a balance between prediction accuracy 150 and biological insight. 151 152 DIABLO identifies molecular networks with superior biological enrichment 153
To assess this, we turn to real biological datasets. We applied various integrative approaches to 154 cancer multi-omics datasets (mRNA, miRNA, and CpG)colon, kidney, glioblastoma (gbm) 155 and lungand identified multi-omics biomarker panels that were predictive of high and low 156 survival times ( Table 1) . We then compared the network properties and biological enrichment of 157 the selected features across approaches. 158
Multi-omics biomarker panels were developed using component-based integrative 159 approaches that also performed variable selection: supervised methods included concatenation 160 and ensemble schemes using the sPLSDA classifier [14] , and DIABLO with either the null or 161 full design (DIABLO_null, and DIABLO_full); unsupervised approaches included sparse 162 generalized canonical correlation analysis [15] (sGCCA), Multi-Omics Factor Analysis 163 (MOFA), and Joint and Individual Variation Explained (JIVE) [23] (see Supplementary Note 164 for parameter settings). Both supervised and unsupervised approaches were considered in order 165 to compare and contrast the types of omics-variables selected, network properties and biological 166 enrichment results. A distinction was made between DIABLO models in which the correlation 167 between omics datasets was not maximized (DIABLO_null) and those when the correlation 168 between omics datasets was maximized (DIABLO_full). 169
Each multi-omics biomarker panel included 180 features (60 features of each omics type 170 across 2 components). Approaches generally identified distinct sets of features. Fig. 2a depicts 171 the distinct and shared features between the seven multi-omics panels obtained from the 172 Discussion 288 DIABLO aims to identify coherent patterns between datasets that change with respect 289 different phenotypes. This purely data-driven, holistic, and hypothesis-free tool can be used to 290 derive robust biomarkers and, ultimately, improve our understanding of the molecular 291 mechanisms that drive disease. 292
We found that unsupervised methods identified features that formed strong 293 interconnected multi-omics networks, but had poor discriminative ability. In contrast, features 294 identified by supervised methods were discriminative, but formed sparsely connected networks. 295
This trade-off between correlation and discrimination is a fundamental challenge when trying to 296 identify biologically relevant biomarkers that are also clinically relevant [31] . DIABLO controls 297 this trade-off by incorporating a priori relationships between different omic domains to 298 adequately model dysregulated biological mechanisms between phenotypic conditions. This may 299 explain the superior biological enrichment of the DIABLO_full models in our benchmarking 300 experiments where the mRNA and miRNA expression as well as methylation activity were 301 assumed to be correlated ( Table 2) . Since these omic domains are known to form real regulatory 302 relationships in order to control complex biological processes, these multi-omic biomarker 303 panels may be capturing this biological complexity. In contrast, these biomarkers were not 304 uncovered when no association was assumed between omic datasets, as in the case of the 305 DIABLO_null models and existing multi-step integrative strategies. Therefore, by controlling the 306 trade-off between correlation and discrimination, DIABLO uncovered novel multi-omics 307 biomarkers that have not previously been identified using existing integrative strategies. These 308 novel biomarkers were part of densely connected clusters of omic variables which have prior 309 known biological associations, further suggesting their potential biological plausibility. 310
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There are areas of improvement that DIABLO will benefit from in the near future. The 311 assumption of linear relationship between the selected omics features to explain the phenotypic 312 response may not apply in some biological research areas, for example when integrating 313 distance-based metagenomics studies, where kernel approaches could be further explored [32] . 314
Selecting the optimal number of variables requires repeated cross-validation to ensure unbiased 315 classification error rate evaluation. A grid approach was deemed reasonable and provided very 316 good performance results, but several iterations to refine the grid may be required depending on 317 the complexity of the classification problem. The grid search algorithm was recently improved 318
[12], but we advise using a broad filtering strategy to alleviate computational time when dealing 319 with extremely large datasets (e.g. > 50,000 features each The result is the identification of variables that are highly correlated between and within omics 371 datasets. 372 Equation (1) describes the sGCCA model for the first dimension. Once the first set of 373 coefficient vectors 1 and associated component scores 1 = 1 are obtained, residual 374 matrices are calculated during the 'deflation' step for the second dimension, such that 2 = 375 1 − 1 1 , where 1 is the original centered and scaled data matrix. The subsequent set of 376 components scores and coefficient vectors are then obtained by substituting by 2 in (1). This 377 process is repeated until a sufficient number of dimensions (or set of components) is obtained. 378
The underlying assumption of the sGCCA model is that the major source of common 379 biological variation can be extracted via the first sets of component scores , while any 380 unwanted variation due to heterogeneity across the datasets XK does not impact the statistical 381 model. The optimization problem (1) is solved using a monotonically convergent algorithm [15] . 382 18 383 DIABLO for supervised analysis and prediction. To extend sGCCA for a classification 384
framework, we substitute one omics dataset Xk in (1) with a dummy indicator matrix Y of size (n 385
x G), where G is the number of phenotype groups that indicate the class membership of each 386 sample. In addition, and for easier use of the method, we replaced the l1 penalty parameter λk by 387 the number of variables to select in each dataset and each component, as there is a direct 388 correspondence between both parameters. 389
Denote a new sample i which is measured across the different types of omics datasets , 390 its class membership is predicted by the fitted sGCCA model with the estimated variable 391 coefficients vectors ̂ to obtain the predicted scores , = ̂, = 1, … , . Therefore, to 392 each dataset k corresponds a predicted continuous score , . The predicted class of sample i for 393 each dataset is obtained from the predicted score using one of the distances Maximum, Centroids 394 or Mahalanobis [37] as described in [12] . The consensus class membership is determined using 395 either a majority vote, or by averaging all , across all K datasets before using the prediction 396 distance of choice ('average prediction' scheme ). In case of ties in the majority vote scheme, 397 'NA' is allocated as a prediction but is counted as a misclassification error during the 398 performance evaluation. As the class prediction relies on individual vote from each omics set, 399 DIABLO allows for some missing datasets during the prediction step, as illustrated in the 400 Breast Cancer case study. We used the centroid distance for the weighted majority vote scheme 401 (breast cancer study) and the maximum distance for the average vote scheme (asthma study) as 402 those led to best performance (see [12] for details about distance measures and voting schemes 403 that can be used). 404
405
Design matrix in DIABLO. The design matrix C is a ( x ) matrix with values ranging from 0 406 to 1 which specifies whether the covariance between two datasets should be maximized 407 DIABLO (see equation (1)). In our simulation study, we evaluated two scenarios: a null design 408 (DIABLO_null) when no omics datasets are connected, and a full design when all datasets are 409 connected (DIABLO_full): 410 411 However, every dataset is connected to the outcome Y internally in the method. For the two case 412 studies (breast cancer and asthma) the design matrix was chosen based on our proposed method 413 (see below Parameters tuning). Note that the design matrix is not restricted to 0 and 1 values 414 only and a compromise between correlation and discrimination can also be modelled as 415 described in [12] . 416 417 Input data in DIABLO. While DIABLO does not assume particular data distributions, all 418 datasets should be normalized appropriately according to each omics platform and preprocessed 419 if necessary (see normalization steps described below for each case study). Samples should be 420 represented in rows in the data matrices and match the same sample across omics datasets. The 421 phenotype outcome Y is a factor indicating the class membership of each sample. The R function 422 in mixOmics will internally center and scale each variable as is conventionally performed in 423 PLS-based models and will create the dummy matrix outcome from Y. A multilevel variance 424 decomposition option is available for repeated measures study designs (see below). The first parameter to tune is the design matrix C, which can be determined using either prior 428 biological knowledge, or a data-driven approach. The latter approach uses PLS method 429 implemented in mixOmics that models pair-wise associations between omics datasets. If the 430 correlation between the first component of each omics dataset is above a given threshold (e.g. 431 0.8) then a connection between those datasets is included in the DIABLO design as a 1 value. 432
The second parameter to tune is the total number of components. In several analyses we 433 found that G − 1 components were sufficient to extract sufficient information to discriminate all 434 phenotype groups [14] , but this can be assessed by evaluating the model performance across all 435 specified components (described below) as well as using graphical outputs such as sample plots 436 to visualize the discriminatory ability of each component. 437
Finally, the third set of parameters to tune is the number of variables to select per dataset 438 and per component. Such tuning can rapidly become cumbersome, as there might be numerous 439 combinations of selection sizes to evaluate across all K datasets. For the breast cancer study, we 440 used 5-fold cross-validation repeated 50 times to evaluate the performance of the model over a 441 grid of different possible values of variables to select (Supplementary Fig. 8 ). The performance 442 of the model for a given set of parameters (including number of component and number of 443 variables to select) was based on the balanced classification error rate using majority vote or 444 average prediction schemes with centroids distance. The balanced classification error rate is 445 useful in the case of imbalanced class sizes, where the majority classes can have strong influence 446 on the overall error rate. The balanced error rate measure calculates the weighted average of the 447 individual class error rates with respect to their class sample size. In our experience, the number 448 of variables to select in each dataset provided less of an improvement on the error rate compared 449 to tuning the number of components. Therefore, even a grid composed of a small number of 450 variables (<50 with steps of 5 or 10) may suffice as it does not substantially change the 451 classification performance. This is because of the use of regularization constraints which reduces 452 the variability in the variable coefficients and thus maintains the predictive ability of the model. genes in the module [18] . For the asthma study, 15,683 genes were reduced to 229 KEGG 507 pathways and 292 metabolites were reduced to 60 metabolic pathways using eigengene 508 summarization. 509
510
Multilevel transformation: For multivariate analyses, A multilevel approach separates the 511 within subject variation matrix (Xw) and the between subject variation (Xb) for a given dataset (X) 512
[42], ie. X = Xw + Xb. In the case of a two-repeated measured problem (e.g. pre vs post 513 challenge), the within subject variation matrix is similar to calculating the net difference for each 514 individual between the data obtained for pre and post challenge. For each omics dataset, the 515 within-subject variation matrix was extracted prior to applying DIABLO. In the asthma study, 516 the multilevel approach (called variance decomposition step) was applied to the cell-type, gene 517 and metabolite module datasets. Variables   database  KRAS  KIT  PXN  PDK1  BRAF1  ERRFI1  CTNNB1  GAB2  IGFBP2  PTEN  CTNNA1  STAT5A  SMAD4  YWHAE  PDCD4  RPS6KB1  CDK1  ASNS1  BAK1  NOTCH1  XRCC1  AR1  CHEK2  STAT3  PGR1  BCL2  ACACA ACACB  CDH1  BCL21  MAPK14  CCNB11  SCD1  CCNB1  PGR  ACACA  MTOR  MAPK9  INPP4B  KIT1  PEA15  CDH3  COL6A1  CHEK21  ASNS  EGFR  CLDN7  CCNE1  ANXA1  AR  PRKCA  CAV1  BRAF  GATA3  ESR1 
